Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
0.9459
-0.0087 (-0.91%)
At close: Sep 15, 2025, 4:00 PM EDT
0.9153
-0.0306 (-3.24%)
After-hours: Sep 15, 2025, 7:23 PM EDT
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $12.24 million as of September 15, 2025. Its market cap has decreased by -62.11% in one year.
Market Cap
12.24M
Enterprise Value
1.78M
1-Year Change
-62.11%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $12.24M, a decrease of -73.28%. That is a compound annual growth rate of -13.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 12.40M | -55.40% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |